<?xml version="1.0" encoding="UTF-8"?>
<ref id="bibr60-0004563220928361">
 <label>60</label>
 <mixed-citation publication-type="other">
  <collab>HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19</collab>, 
  <ext-link ext-link-type="uri" xlink:href="http://www.acc.org/latest-in-cardiology/articles/2020/03/17/08/59/hfsa-acc-aha-statement-addresses-concerns-re-using-raas-antagonists-in-covid-19" xmlns:xlink="http://www.w3.org/1999/xlink">www.acc.org/latest-in-cardiology/articles/2020/03/17/08/59/hfsa-acc-aha-statement-addresses-concerns-re-using-raas-antagonists-in-covid-19</ext-link> (2020, accessed 24 April 2020).
 </mixed-citation>
</ref>
